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Abstract
Background: Osteoarthritis (OA) is a prevalent chronic disease and a leading cause of disability in adults. For
people with knee and hip OA, symptoms (e.g., pain and fatigue) can interfere with mobility and physical activity.
Whereas symptom management is a cornerstone of treatment for knee and hip OA, limited evidence exists for
behavioral interventions delivered by rehabilitation professionals within the context of clinical care that address
how symptoms affect participation in daily activities. Activity pacing, a strategy in which people learn to preplan
rest breaks to avoid symptom exacerbations, has been effective as part of multi-component interventions, but
hasn’t been tested as a stand-alone intervention in OA or as a tailored treatment using accelerometers. In a pilot
study, we found that participants who underwent a tailored activity pacing intervention had reduced fatigue
interference with daily activities. We are now conducting a full-scale trial.
Methods/Design: This paper provides a description of our methods and rationale for a trial that evaluates a
tailored activity pacing intervention led by occupational therapists for adults with knee and hip OA. The
intervention uses a wrist accelerometer worn during the baseline home monitoring period to glean recent
symptom and physical activity patterns and to tailor activity pacing instruction based on how symptoms relate to
physical activity. At 10 weeks and 6 months post baseline, we will examine the effectiveness of a tailored activity
pacing intervention on fatigue, pain, and physical function compared to general activity pacing and usual care
groups. We will also evaluate the effect of tailored activity pacing on physical activity (PA).
Discussion: Managing OA symptoms during daily life activity performance can be challenging to people with
knee and hip OA, yet few clinical interventions address this issue. The activity pacing intervention tested in this trial
is designed to help people modulate their activity levels and reduce symptom flares caused by too much or too
little activity. As a result of this trial, we will be able to determine if activity pacing is more effective than usual
care, and among the intervention groups, if an individually tailored approach improves fatigue and pain more than
a general activity pacing approach.
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Background
Osteoarthritis (OA) is a prevalent and chronic disease. It
affects over 27 million adults in the U.S. and is expected
to increase as the population ages [1]. OA is more pre-
valent among females, however, male veterans are also
significantly affected, with 1/3 of males of all ages diag-
nosed and nearly half of those who use the Veteran’s
Affairs (VA) healthcare system [2]. OA causes substan-
tial physical and psychosocial disability. By 2020, it is
expected that 12 million people in the U.S. will report
activity limitations due to arthritis [3].
A primary reason people with OA seek treatment is
for pain relief. Whereas people with OA often receive
pharmacological treatment for pain reduction, non-
pharmacological treatment for symptoms is considered
the foundation of OA management [4,5]. Rehabilitation
professionals, such as occupational therapists (OTs), can
tailor non-pharmacological symptom management inter-
ventions so as to promote adherence and behavior
change. To date, however OTs have had only limited
involvement in tailoring such interventions for people
with OA. More research is needed on the effectiveness
of these tailored symptom management interventions
when delivered by rehabilitation professionals within the
context of clinical care. Well-established community-
based programs on self-management strategies (such as
the Arthritis Self-Management Program) have been
shown to have small but positive effects on pain and
arthritis self-efficacy [6-8]. Although community-based
programs are an important tool for OA management,
such programs do not optimize the use of rehabilitation
professionals in the delivery or tailoring of these
programs.
Behavior Change and Tailoring Interventions
A tailored approach to interventions is being increas-
ingly recommended in order to make the content per-
sonally relevant and to promote long-term behavior
change. Several interventions are individually tailored on
key variables identified in theoretical health behavior
models, such as motivational readiness, decisional bal-
ance, or self-efficacy [9-11]. Interventions also have been
tailored on personal characteristics (e.g., gender [12],
depression [13], pain level [14]). There is growing evi-
dence that tailoring enhances the effectiveness of clinical
interventions designed to alter health risk behaviors
such as smoking [15,16] and low physical activity
[17,18].
For arthritis management interventions, Social Cogni-
tive Theory has often been used as the theoretical foun-
dation of intervention development [19,20]. It posits
that people learn through an interaction of social and
environmental influences that contribute to their own
motivations and behaviors [21]. To adopt a new health
behavior, the central determinants include 1) knowledge
of the risks and benefits, 2) outcome expectations about
costs and benefits for engaging in health behaviors, 3)
the health goals people set for themselves and plans for
goal achievement, 4) the perceived facilitators and bar-
riers (such as external social or work demands), and 5)
self-efficacy, the belief in the ability to perform under a
certain set of conditions [21,22]. Self-efficacy is often a
central focus in self-management interventions because
it influences behavior both directly and indirectly
through the other determinants above [22]. Numerous
studies have found that improvements in pain coping
skills are related to improvements in arthritis self-effi-
cacy [19,23,24].
In this study, the intervention is designed to assist
people in enhancing their arthritis self-efficacy by indivi-
dually tailoring the use of activity pacing strategies to
the context of where and when the strategies may be
most useful. According to Social Cognitive Theory, self-
efficacy is enhanced by building competency through
practice (and by the rewards associated with success) in
specific situations or conditions [22]. By tailoring activity
pacing instruction to individuals’ real-life routines and
activities, there is a greater chance for learning to occur
and for self-efficacy to be enhanced given the greater
proximity of the pacing schedule to real-life and person-
ally relevant activities.
Pain, Fatigue, and Their Relationship to Physical Activity
Both pain and fatigue symptoms are linked to various
functional problems in OA. Pain in OA affects the abil-
ity to engage in activities of daily living, work, and other
meaningful activities and is associated with a reduced
quality of life [25-27]. Fatigue is not as well-studied in
OA, however, it is one of the most frequently reported
OA symptoms [28,29]. Attention to the clinical impor-
tance of fatigue is growing. In large studies, substantial
fatigue was reported by 41% of patients with OA [28],
and problematic fatigue or tiredness was reported in
moderate levels [30]. Fatigue in OA is one of the stron-
gest predictors of functional disability [28,31] and work
dysfunction [28]. Fatigue has also been associated with
pain, sleep problems, functional disability, and depres-
sion [28,30-32]. Qualitative studies have further charac-
terized the fatigue experience in OA as debilitating,
causing activity restriction, and greatly impacting life
[29,33].
A better understanding of how symptoms affect activ-
ity on a more micro level, such as over a day, week, or
month, can help refine and tailor OA interventions. For
example, tailored interventions may target timing of
behaviors such as medication usage or variability in
symptoms by time [34]. Although OA symptoms are
believed to be less variable than other rheumatic
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conditions such as rheumatoid arthritis (RA), an emer-
ging body of research has shown that there is important
variability in OA pain [35-38] across days or even within
a day. These pain fluctuations have been associated with
limited daily activities, days of missed work, sleep inter-
ference, and mood [36], and increased pain variability
may be associated with personal factors [e.g., body mass
index (BMI)] [35].
Fewer studies have examined fatigue variability in OA.
Given the strong relationship between pain and fatigue
[28,31,32] in OA and other conditions, it is not surpris-
ing that fatigue is often considered a by-product of
pain. However, when pain and fatigue are measured
daily or within-day, differences emerge. For example,
compared to samples of persons with RA and fibro-
myalgia, daily fatigue fluctuations were not as strongly
associated with daily pain fluctuations in persons with
OA [39]. In our work, we found that within-day fatigue
was experienced at greater intensities than was pain
[40]. Additionally, in one of the few studies to examine
the symptom-activity relationship in OA, we found that
fatigue was more highly associated with objective physi-
cal activity (PA; measured by accelerometer) compared
to pain [40]. Lastly, we found differential effects for
pain and fatigue by group when we tailored activity
pacing [41], providing support for addressing pain and
fatigue separately.
Pacing Intervention Effectiveness
Although activity pacing is a recommended non-phar-
macological intervention for OA management based on
consensus guidelines [4], its effectiveness as a stand-
alone intervention is understudied. Typically, activity
pacing is combined with other programs (e.g., coping
skills training, cognitive behavioral therapy). In these
studies of knee or hip OA, the overall programs have
been effective at reducing pain [23,24]; however, it is
impossible to disentangle the unique effects of activity
pacing. Due to differences in how activity pacing is
understood as a strategy, there is variability in activity
pacing instruction and its delivery by therapists [42,43].
This trial addresses these limitations by using a standar-
dized approach to teaching activity pacing to adults with
knee or hip OA. This approach is structured around the
overall goal of activity pacing, which is the balance
between activity and rest in order to accomplish neces-
sary and valued activities [44]. In this study, we will also
be able to examine the unique effects of tailored activity
pacing on fatigue for knee or hip OA in which our pre-
liminary results showed significant improvements in fati-
gue compared to a general activity pacing intervention
[41]. The conceptual model that guided intervention
development is shown in Figure 1.
Methods/Design
This is a three-arm randomized controlled trial that will
examine outcomes at baseline, posttest (approximately
10 weeks post baseline), and 6 months. Ethical approval
for this study was obtained by the University of Michigan
Medical School Institutional Review Board and the Sub-
committee on Human Studies in the Veteran’s Affairs
Ann Arbor Healthcare System. The overall goal of the
study is to examine the effectiveness of a tailored activity
pacing intervention for adults with symptomatic knee or
hip OA. The primary outcomes are fatigue and pain.
The specific aims are:
Aim 1: To examine the effectiveness of a tailored
activity pacing intervention on fatigue, pain, and physi-
cal function.
Aim 2: To determine if increased arthritis self-efficacy
post intervention is related to improvements in symp-
tom severity and function.
Aim 3 Aim 1 
  OUTCOMES 
Tailored 
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Figure 1 Model of Symptoms, Self-Efficacy, Physical Function and PA in Adults with Osteoarthritis.
Murphy et al. BMC Musculoskeletal Disorders 2011, 12:177
http://www.biomedcentral.com/1471-2474/12/177
Page 3 of 10
Aim 3: To evaluate the effect of tailored activity
pacing on physical activity.
Eligible individuals are randomly stratified by age and
gender into one of three arms: tailored activity pacing
intervention, general activity pacing intervention, or
usual care. The tailored and general activity pacing
interventions are equivalent in session number and
length. Participants are involved in study procedures
over 6 months. For the intervention groups, involvement
consists of 3 individual sessions, 3 testing visits, 3 home
monitoring periods, 3 weekly follow-up phone calls, and
monthly contact phone calls until the outcome assess-
ment at 6 months. The usual care group participates in
all activities described above except for the intervention
sessions and the 3 weekly follow-up phone calls.
Participant Recruitment
Community-living veteran and non-veteran participants
are recruited from the University of Michigan and VA
clinics, senior housing sites, and through public adver-
tisements. Based on our previous studies, our optimal
recruitment methods are ad placement at clinics and
through community ads and fliers. As in our previous
studies, areas with higher concentrations of minorities
are particularly targeted for recruitment. Minorities such
as African Americans are particularly important to
include in this study because they not only have higher
rates of knee and hip OA than Caucasians [45], they
also report more severe OA symptoms and more physi-
cal disability even when controlling for demographics
and other factors [46]. In addition, African Americans
are less likely than Caucasians to opt for hip or knee
replacements [47] and more likely to manage OA
through home remedies that often have little to no evi-
dence of effectiveness (such as copper bracelets or her-
bal medicines) [48].
Eligibility Criteria
The following inclusion criteria were designed to iden-
tify a cohort of community-living adults who are likely
experiencing symptoms specifically due to their OA.
Prior to enrollment, each prospective participant is eval-
uated for inclusion. Table 1 lists the inclusion and
exclusion criteria.
Procedures
Figure 2 shows a flow chart of the study protocol. In
brief, trained research personnel screen individuals for
eligibility, administer performance-based assessments,
and train participants in the use of the wrist-worn accel-
erometer and accompanying logbook. Participants pro-
vide written consent to participate in the study. They
wear the accelerometer for a 7 day period and then
return materials in person or by mail to the study team.
Participants are randomly stratified by age and gender
into the tailored activity pacing intervention, general
activity pacing intervention, or usual care group. The
usual care group participants undergo all outcome
assessments and have maintained contact through
monthly emails between outcome assessments similar to
the intervention groups. The contact period between
Weeks 11 - 23 is being undertaken to better ensure par-
ticipation in the 6 month assessment for all groups.
Each intervention arm involves 3 individual sessions
with an OT. In the tailored activity pacing group, data
collected from the home monitoring period are used to
generate reports for participants about how symptoms
relate to physical activity and are used by the occupa-
tional therapist. The general activity pacing group does
not use the information from the home monitoring per-
iod during OT sessions.
Study Arms
Usual Care Group
This group participates in all outcome measures and
monthly outcomes are tracked during the study period
using a survey measure to determine if any new OA
pharmacological or non-pharmacological treatments are
undertaken (e.g., injection, physical therapy, medication
change) to treat symptoms.
Table 1 Eligibility Criteria
Inclusion Criteria
• Age ± 50 years old
• Pain for at least 3 months duration
• Mild to moderate severity on the WOMAC pain scale
• Radiographic evidence of knee or hip OA
• Community-living (i.e, own home, senior residence, apartment)
• Adequate cognitive status (score of > 5 on the 6-Item Screener)
[66]
• Ambulatory either with or without an assistive device
• Reliable operation of the Actiwatch-Score accelerometer
• English-speaking
Exclusion Criteria
• Medical conditions that may interfere with pain and fatigue
reporting or activity monitoring (multiple sclerosis, lupus,
rheumatoid arthritis, Parkinson’s disease, peripheral neuropathy)
• Cancer diagnosis in the last year (other than skin cancer) or
currently undergoing treatment for cancer
• Medicine changes within last 2 weeks
• Anemia or unmanaged thyroid dysfunction (from blood work
result)
• 2 or more days of complete bed rest within last month
• Limb hemiplegia or amputation
• Knee arthroscopic procedure within the last 2 months
• Replacement of any hip or knee within the last 6 months
• Knee joint injection within the last 3 months
• Current receipt of physical or occupational therapy for OA
symptoms or knee/hip problems
• Current attendance or attendance in the past 12 months in a
cognitive behavioral program or other self-management program
that includes activity pacing instruction.
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General and Tailored Activity Pacing Interventions
Regardless of whether people are assigned to the tai-
lored activity pacing or general activity pacing interven-
tion groups, participants meet with an OT for 3
individual sessions (total treatment time: 3 hours over
Weeks 4 - 9 of the study). The first session for both the
tailored activity pacing and general activity pacing
includes a brief presentation by the OT on the nature of
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Figure 2 Study Flow Chart.
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OA and how physical demand and mood can affect the
symptom experience. This is followed by group-specific
instruction on activity pacing as a tool for symptom
management which includes printed materials that are a
take-home reference for the participant. In the tailored
activity pacing intervention, the OT discusses how to
incorporate activity pacing based on the individual’s pro-
file of symptoms and activities determined from the
baseline home monitoring period. In the general activity
pacing intervention, the OT uses generic examples and
does not mention the individual symptom experience
from the baseline home monitoring period. By the end
of the first OT session for both the tailored and general
activity pacing groups, the participants develop a time-
based activity plan with goals related to activity pacing.
The second session focuses on individual progress with
activity pacing, goal setting, and addressing barriers to
using the recommended strategies. The third session
focuses on reviewing activity pacing tenets, evaluating
the use of time based activity pacing and planning for
the future. After the 3 individual sessions have con-
cluded, the OT makes 3 brief follow-up phone calls (1
call per week) to discuss activity pacing progress, symp-
toms, and any barriers.
Strategies for Ensuring Treatment Fidelity
Treatment fidelity is defined as “the procedures used to
monitor and enhance the reliability and validity of beha-
vioral interventions [49],” and is an essential component
of this study. Per recommendations from the National
Institutes of Health (NIH) behavior change consortium
[49,50], several strategies are being used to ensure treat-
ment fidelity in this study. These strategies target fidelity
of treatment delivery (standardized modules for the
intervention and interventionist training and monitor-
ing) and treatment receipt (i.e., participant involvement
in treatment).
Fidelity of Treatment Delivery
We have designed the study such that both intervention
groups are equivalent in dose and administration of
treatment (i.e., the number and length of sessions),
including the manner in which participants are con-
tacted from 10 weeks through 6 months. There are sev-
eral procedures in place to ensure fidelity in how
treatment is delivered. It is likely that there will be mul-
tiple therapists per active intervention arm (i.e., tailored
activity pacing and general activity pacing). We decided
that extra therapists per group could reduce the possibi-
lity of treatment effect due to therapist characteristics
and ensure that we can deliver the intervention in the
event that any interventionists drop out of the study. All
therapists will undergo an initial training period which
will involve structured education via a manual and a
series of didactic sessions with the principal investigator
(PI) and study team members. The initial training will
also involve role playing in pairs and an observer who
will rate the mock treatment session for key concepts to
ensure consistency across therapists. Any discrepancies
in how the intervention is delivered across therapists
will be discussed and a consensus will be reached about
intervention delivery.
To assess therapist adherence to the intervention pro-
tocol, they are asked to log the actual treatment time
per session with each individual. The therapist also has
a checklist of items for each visit to facilitate consistent
presentation of the protocol. In addition, we are audio-
taping sessions (as long as each individual consents to
that process) and an independent rater listens to the
tapes shortly after the sessions to determine if original
criteria for intervention delivery in each treatment arm
are being met. Any discrepancies in the audiotapes by
therapists in a particular treatment arm will be resolved
in a face-to-face meeting through consensus to reduce
any variability in delivery. To prevent protocol ‘drift’,
the PI and therapists in each arm have monthly tele-
phone contact to discuss any issues and additional train-
ing sessions among therapists occurs as needed.
Fidelity of Treatment Receipt
We will also assess participant factors related to treat-
ment fidelity, i.e., how the treatment is received by the
participant. This involves an assessment of individual
factors such as comprehension of information, and the
ability to use and perform skills associated with both the
data collection and behavioral elements of the study. We
have a standardized interactive learning module to teach
the participant how to input symptoms on the wrist-
worn accelerometer. Because the validity of the symp-
tom information is central to our tailoring methods, all
participants will undergo this learning module prior to
their first session with the OT. In addition, both the tai-
lored and general activity pacing interventions include
strategies to ensure comprehension of the material. For
example, participants are asked to reiterate main pacing
concepts back to the therapist (e.g., importance of plan-
ning, resting before symptoms get worse, etc.). Partici-
pants also receive homework assignments that reinforce
the lessons presented during the session and are asked
to complete a daily activity logbook. Both of these
homework items are used to assess personal compliance
and overall protocol adherence. Each subsequent session
involves a review of previously presented topics, a
review of goals, and time for discussion of any barriers.
Session 3 is focused on relapse-prevention, and con-
tinues the theme of setting goals and problem-solving to
minimize barriers that impede the use of activity pacing.
Lastly, we conduct debriefing interviews with each
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participant to examine their experiences in the interven-
tion including adherence with activity pacing in daily
life at the end of their involvement in the study.
Measures
The primary outcome measures are fatigue and pain.
Fatigue is assessed in two ways. First, fatigue is mea-
sured by the Brief Fatigue Inventory (BFI) [51], a reliable
and valid measure of fatigue in adults with cancer.
There is no gold standard measure of fatigue for adults
with OA; however, the BFI is of particular relevance
because it assesses fatigue by asking about interference
in daily life, which is our primary interest. This scale is
usually scored by calculating an overall score based on
an average of 9 of the 10 items. In samples with rheu-
matic conditions, the BFI has recently been divided into
two fatigue subscales (fatigue severity and fatigue inter-
ference) [52]. Although no studies have examined the
clinical significance of these subscales in OA or in other
samples, we are expecting similar or greater improve-
ments in fatigue severity and fatigue interference as seen
in our pilot study (8% and 15% improvement respec-
tively) [41]. Second, because there is currently no com-
monly-used fatigue measure in OA across studies, an
additional method of assessing fatigue from the Patient-
Reported Outcomes Measurement (PROMIS) assess-
ment tools will be used. PROMIS is a collection of care-
fully constructed item banks that can be used to assess
multiple domains of relevance to complex and chronic
illnesses. Due to the methods used to construct these
item banks, such measures are expected to be more pre-
cise and less burdensome to patients to complete [53].
We are using the 8-item short form PROMIS fatigue
scale [54]. Pain, the other primary outcome, is assessed
by the Western Ontario and McMaster Universities
Osteoarthritis Index (WOMAC). This is a validated, dis-
ease-specific questionnaire for adults with knee or hip
OA in which participants rate their currently experi-
enced pain and physical disability [55]. Based on pre-
vious studies, we will consider a 2 point decrease on the
WOMAC pain scale to be clinically significant [56].
Other secondary outcomes and potential moderators
include physical function, assessed by the 6 Minute
Walk Test [57], a commonly used, validated measure of
physical performance in adults; arthritis self-efficacy, the
perceived ability to manage arthritis and pain and fati-
gue symptoms, measured by the Arthritis Self Efficacy
Scale [58]; and other variables such as knee extension
strength (as measured by a hand-held dynamometer),
and general health status variables (e.g., BMI, self-
reported chronic conditions, depression using the Geria-
tric Depression Scale [59], medication use). In addition,
PA will be assessed by a wrist-worn accelerometer [Acti-
watch-Score, Phillips Respironics-Mini Mitter Co, Bend
OR] that measures changes in acceleration. Although it
is worn on the wrist, it is highly associated with whole-
body movement [60,61]. Changes in acceleration are
recorded as activity counts and saved every 15 seconds.
Higher activity counts reflect participation in higher
intensity activities [62,63]. PA from the accelerometer
will be aggregated in different ways. We will look at
average activity counts and total activity counts that
occur: 1) in the time between symptom reporting peri-
ods, 2) over each day, and 3) over the entire home mon-
itoring period similar to our previous studies [40,41,64].
Procedure for the Home Monitoring Periods
The accelerometer is mounted on each participant’s
non-dominant wrist. Participants are instructed on how
to enter responses into the accelerometer using a stan-
dardized interactive learning module that we have devel-
oped and used in previous studies. Participants are given
the opportunity to practice rating their symptoms and
using the accelerometer’s input button to record the
information. If, for some reason, participants fail the
learning module (e.g., inability to rate symptom experi-
ence on a numeric rating scale, inability to press the
input button) they are excluded. Although we have not
encountered exclusion for this reason in any of our past
studies, this reporting is central to the tailoring portion
of the intervention and therefore is an important criter-
ion for study inclusion. Participants also become familiar
with the logbook that accompanies the accelerometer
and serves to cross-validate the items. The logbook is
used as a back-up if there are missing data from the
accelerometer.
Momentary pain and fatigue severity are measured on
0 -10 numerical rating scales that will be directly input
into the accelerometer five times a day (at rise time in
the morning, 3 times during waking hours, and at bed-
time). The accelerometer is worn for 7 days at baseline
and at the outcome assessment periods. Pain is rated on
a scale from 0 = no pain to 10 = pain as bad as you can
imagine. Fatigue, defined as tiredness or weariness [28],
is rated on a scale from 0 = no fatigue to 10 = fatigue
as bad as you can imagine. Momentary ratings are used
in the study for the sole purpose of generating tailored
reports on individual symptom-activity relationships
during the baseline week for the tailored activity pacing
intervention.
Data Analysis
The target sample size in this study is 156 participants.
In our recruitment plans, we have factored in a 30%
attrition rate to achieve this number. Although there are
three arms to the study: tailored activity pacing, general
activity pacing, and usual care group, the study was
powered to find effects between the two active
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intervention groups (tailored activity pacing and general
activity pacing). Specifically, the power analysis was
based on our pilot data in which we compared the tai-
lored activity pacing intervention with the general activ-
ity pacing intervention and detected large group
differences using the effect size Cohen’s d [65] on BFI
fatigue severity and interference (d = .79 and 1.1 respec-
tively) at 10 week-follow-up. Based on a 2 group t-test
at a significance level of p = .05, we will have greater
than 90% power to detect an effect size of .74 or larger
with 40 people in each of the two active intervention
groups. Because most people with OA do not receive
this type of intervention, it is important to compare the
active intervention groups to a group receiving usual
care. The study was powered to detect treatment effects
between the active intervention groups; therefore we
will also have sufficient power to detect differences
between the active intervention groups and usual care
group.
To examine the effectiveness of a tailored activity
pacing intervention on fatigue, pain, and physical func-
tion, we will use repeated measures analysis of variance
(RM ANOVA) models to analyze the responses (pain,
fatigue, and 6 minute walk test) at baseline, 10 weeks,
and 6 months for the three treatment groups (tailored
activity pacing, general activity pacing, and usual care
group). This will allow us to estimate the effects of
treatment group, time point and the treatment × time
interaction. Similarly, we will use RM ANOVA models
to determine if increased arthritis self-efficacy post
intervention is related to improvements in symptom
severity and function and to evaluate the effect of tai-
lored activity pacing on physical activity.
Discussion
Although non-pharmacological treatment is recom-
mended for people with knee and hip OA to manage
symptoms, much of the evidence-base has examined
these strategies in the context of a program of skills
rather than individually. This study is examining the
effect of a brief, individually-tailored, OT-led activity
pacing intervention on pain and fatigue in adults with
knee and hip OA. Given the positive effects of the tai-
lored activity pacing approach compared to general
activity pacing on fatigue in a small pilot study, we
hypothesize that fatigue in particular will be improved
with the tailored activity pacing intervention. We will
also explore arthritis self-efficacy as a potential mechan-
ism of change and the effects of pacing on PA at the 6
month follow-up period in an exploratory analysis.
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